First, to our knowledge, it is the first to quantitatively compare different insulin infusion methods in the treatment of PN-associated hyperglycemia, which can more accurately assess the safety and efficacy between different insulin infusion modalities and remedy the deficiencies in current published studies. The gene discussed is INS; the disease is Hyperglycemia.